Med-Metrix | AI Transformation Index
Med-Metrix is a high-opportunity, moderate-durability RCM services company sitting at a structural inflection point: its core production function is almost...

Overview
Med-Metrix is a technology-enabled Revenue Cycle Management (RCM) outsourcer that generates revenue by helping healthcare providers optimize claims management, denials management, patient accounting, and revenue recovery through hybrid human-AI workflows.
Executive Summary
Med-Metrix is a high-opportunity, moderate-durability RCM services company sitting at a structural inflection point: its core production function is almost entirely cognitive labor that AI can compress dramatically, but that same characteristic makes it vulnerable to AI-native RCM platforms and in-house provider automation eating its outsourcing rationale. The PE thesis depends on accelerating AI transformation faster than platform-layer competition arrives — using AI to restructure the cost base, improve client outcomes, and pivot toward defensible BI/analytics products that justify sustained outsourcing relationships. The window to capture this value is real but time-bounded, as the RCM services layer faces long-run margin compression regardless of who captures the near-term AI efficiency gains.
Durability
How resilient is this business against AI disruption?
Market Substitutability
Profit Pool Migration
Barrier to Entry
Disintermediation Exposure
Switching Costs
Opportunity
How big a deal is AI for this business?
AI Applicability
Improvement Magnitude
Transformation Upside
Domain Intelligence Amplification
60.0
Ciridae AI Score
Durability Rationale
Med-Metrix operates in a structurally challenged position as an intermediary services layer in a market where both upstream EHR platforms and downstream AI-native RCM software are encroaching on the outsourcing rationale. The core deliverable — maximizing provider reimbursement — is a cognitive task with no physical component, making it progressively more replicable by AI tools that providers could deploy in-house or purchase from platform-native competitors. Regulatory complexity and switching costs provide meaningful but not decisive protection; the real durability risk is profit pool migration toward software-layer incumbents with deeper payer data integration and system-of-record positioning.
Opportunity Rationale
Med-Metrix represents a classic high-opportunity RCM services play: nearly the entire production function is cognitive labor, the volume is high (claims, denials, eligibility checks running in thousands per day), and the company's engineering team of 20-40 with moderate-to-advanced sophistication has not yet captured the full AI step-change available to it. The magnitude of improvement is substantial — AI can compress large operational teams into lean augmented workflows — and the transformation upside includes a shift from reactive revenue recovery toward predictive revenue intelligence products. The domain has meaningful proprietary elements in payer-specific denial patterns and managed care strategy, though the bulk of the rules-based coding and adjudication work is LLM-learnable from public sources.
Key Risks
EHR platform consolidation (Epic, Oracle Health) accelerates native RCM AI capabilities and incentivizes large health systems to bring revenue cycle in-house, collapsing Med-Metrix's outsourcing rationale faster than AI transformation can restructure its economics.
Med-Metrix's existing AI/RPA investment may mean the unrealized step-change is smaller than it appears — if the company has already automated the highest-volume rules-based workflows, remaining gains are incremental rather than transformative, and the opportunity assessment is optimistic.
Company Overview
| Headquarters | Parsippany, New Jersey, United States |
| Products / Services | End-to-end Revenue Cycle Management outsourcing, point solutions within the revenue cycle, revenue recovery, denials management, managed care improvement, physician advisor services, contract management, payment variance recovery, patient accounting, patient access services, Med-Metrix University, AI and automation-enabled RCM technology. |
| Deal Partners |
PE / Ownership History
| Event | Details |
|---|---|
Growth investment by funds managed by Harvest Partners, LP in partnership with Med-Metrix management and existing investor A&M Capital. June 24, 2025 | The investment supports Med-Metrix's next phase of development. Financial terms were not disclosed. |
Executives
| Name | Background |
|---|---|
Robert J. Wright President | Robert J. Wright has been President at Med-Metrix for over 15 years. Previously, he held leadership roles at MedAssets, including President of the Revenue Cycle Consulting Division and Revenue Cycle Service Division. He also served as COO at MD-X Solutions. He holds a Bachelor of Business Administration and a Bachelor of Arts and Science in Accounting from Siena College. |
Garett Kreitz Co-President | Garett Kreitz has been Co-President at Med-Metrix for nearly 2 years. His prior experience includes roles at Vertical Performance Partners as Business Development Director for Major Accounts, Regional Director at Biogen Idec, and District Manager at Sepracor. He holds a BA in Economics from the University of Pennsylvania. |
Sheri Ann DaCosta SVP, Finance & CFO | Sheri Ann DaCosta has been SVP, Finance & CFO at Med-Metrix for 6 years. Previously, she worked as Controller at M Space Holdings, LLC, and Assistant Controller at MedAssets. She holds an MBA in Business from William Paterson University of New Jersey. |
Thomas Ryan Executive Vice President, Global Services | Thomas Ryan has been EVP Global Services at Med-Metrix for nearly 4 years. His prior roles include Vice President of Accounts Receivable Services at MedAssets, Director at MD-X Solutions, and Director at McKesson. |
Cristina Stoica Chief Technology Officer | Cristina Stoica has been CTO at Med-Metrix for almost 3 years. She previously held roles at MedAssets including Director and Manager of Data Processing and Analysis. She holds a Bachelor in Computer Science from Universitatea de Vest „Vasile Goldiş” din Arad. |
David Wilson Vice President, Revenue Cycle Transformation Services | David Wilson has been VP at Med-Metrix for over 2 years. He previously worked at Therapy Brands as Vice President of RCM Operations Technology, and held senior roles at Berkeley Research Group LLC and MedeAnalytics Inc. |
Cris Hartigan Vice President | Cris Hartigan has been Vice President at Med-Metrix for over 2 years. Previously, he held senior roles at Atlas Health and nThrive. |
Harvest Partners